Valuation Amarin Corporation plc

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 14/07/2026 +04			5-day change	1st Jan Change
14.70 ^USD	-1.21%		-6.55%	+5.34%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
07-01	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	308.2	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	6.23%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	134.4	120.8	116.2
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-13.58%	-10.13%	-3.74%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-490x	-735x	-368x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	7.4x	22.1x	-4x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.73x	1.94x	2.2x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.76x	0.76x	0.83x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-5.25x	-5.86x	-4.12x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-5.25x	-5.86x	-4.12x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.03	-0.02	-0.04
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	177.8	158.8	140.2
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-12.75	-9.038	-16.28
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	14.70	14.70	14.70
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMARIN CORPORATION PLC	-490x	0.76x	-5.25x	-	308M
WUXI APPTEC CO., LTD.	20.06x	6.16x	13.43x	1.6%	53.54B
ARGENX SE	32.54x	8.23x	25.52x	0.06%	54.18B
INSMED INCORPORATED	-41.84x	13.68x	-39.9x	-.--%	23.66B
BIONTECH SE	-17.97x	4.21x	-7.37x	-.--%	22.78B
WUXI BIOLOGICS (CAYMAN) INC.	24.64x	4.81x	12.68x	-.--%	19.54B
GENMAB A/S	25.1x	4.86x	15.83x	-.--%	17.82B
PHARMAESSENTIA CORPORATION	48x	19.5x	50.21x	0.08%	16.01B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-526.19x	37.05x	-4130.99x	-.--%	15.37B
EXELIXIS, INC.	17.61x	5.12x	11.91x	-.--%	14.09B
Average	-90.80x	10.44x	-405.39x	0.19%	23.73B
Weighted average by Cap.	-20.46x	9.82x	-257.07x	0.38%